Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
33 hedge funds and large institutions have $223M invested in Vigil Neuroscience in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 8 closing their positions.
398% more capital invested
Capital invested by funds: $44.7M → $223M (+$178M)
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
25.51% more ownership
Funds ownership: 61.35% → 86.86% (+26%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less funds holding
Funds holding: 35 → 33 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$15.1M |
| 2 |
DM
Deerfield Management
New York
|
+$15.1M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$13.3M |
| 4 |
AG
Artal Group
Luxembourg
|
+$8.54M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$855K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$135K |
| 2 |
Renaissance Technologies
New York
|
-$97K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$65K |
| 4 |
PHK
Point72 Hong Kong
Hong Kong
|
-$31K |
| 5 |
Morgan Stanley
New York
|
-$23.5K |
VIGL Hedge Fund Activity: Q3 2022 in Review
33 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q3 2022, worth a combined $223M — up 398% from $44.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of VIGL and 6 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 12 added.
The largest buyer was Deep Track Capital, adding an estimated $15.1M. The largest seller was PEAK6 Investments, exiting entirely with an estimated $135K sold.
- 33 institutional investors held Vigil Neuroscience (VIGL) as of Q3 2022, down from 35 in Q2 2022.
- Funds reported $223M of Vigil Neuroscience stock for Q3 2022, up 398% quarter-over-quarter.
- 6 funds opened new Vigil Neuroscience positions in Q3 2022 and 8 closed out, a net change of -2 holders.
- The largest Vigil Neuroscience buyer in Q3 2022 was Deep Track Capital, an estimated $15.1M added.
- The largest Vigil Neuroscience seller in Q3 2022 was PEAK6 Investments, an estimated $135K sold.
Based on aggregated 13F filings for Q3 2022.